Monopar Therapeutics director sells $672,243 of shares
Director Christopher M. Starr sold 8,400 shares at weighted-average prices of $78.09, $78.82, and $79.67. He also exercised options at $0.005. His direct stake is now 5,173 shares, with a total beneficial ownership of 15,053 shares.